Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hamartoma Syndrome, Multiple × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3253 Neoplasms 2509 Prostatic Neoplasms 1475 Colorectal Neoplasms 1220 Lung Neoplasms 1105 Motor Activity 676 Head and Neck Neoplasms 585 Pancreatic Neoplasms 560 Uterine Cervical Neoplasms 555 Colonic Neoplasms 546 Carcinoma, Non-Small-Cell Lung 531 Carcinoma, Hepatocellular 526 Rectal Neoplasms 483 Stomach Neoplasms 455 Brain Neoplasms 404 Ovarian Neoplasms 378 Anxiety Disorders 353 Pain 349 Neoplasm Metastasis 326 Esophageal Neoplasms 324 Polycystic Ovary Syndrome 316 Urinary Bladder Neoplasms 307 Precursor Cell Lymphoblastic Leukemia-Lymphoma 286 Fatigue 275 Multiple Myeloma 272 Melanoma 270 Lymphoma 261 Depression 252 Endometrial Neoplasms 243 Liver Neoplasms 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03630523 2018-08-15

RIPS

Radboud University Medical Center

Phase NA Unknown

Hamartoma Syndrome, Multiple

Data powered by HemOnc (CC BY 4.0) Colophon ⚡